Journal of the American Academy of Dermatology · 2021
Prevalence of depression among children, adolescents, and adults with hidradenitis suppurativa.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wright Shari, Strunk Andrew, Garg Amit
Аннотация
BACKGROUND: Information on prevalence of depression among children, adolescents, and adults with hidradenitis suppurativa (HS) is limited.
OBJECTIVE: To compare prevalence of depression in HS patients with that of controls.
METHODS: Cross-sectional analysis of 38,140 adult and 1162 pediatric HS patients and controls identified using data from electronic health records. Primary outcome was prevalent depression.
RESULTS: Prevalence of depression among adults with HS was 30.0% (95% Confidence interval [CI], 29.6-30.5), compared with 16.9% (95% CI, 16.7-17.1) among controls. Among children and adolescents with HS, prevalence of depression was 11.7% (95% CI, 10.0-13.7), compared with 4.1% (95% CI, 3.6-4.7) among controls. In adjusted analyses, adults and children/adolescents with HS had 1.26 (95% CI, 1.25-1.28; P < .001) and 1.42 (95% CI, 0.999-2.01; P = .051) times the odds of having depression relative to controls, respectively.
LIMITATIONS: We could not evaluate the influence of disease severity on the outcome.
CONCLUSION: Depression is prevalent among children, adolescents, and adults with HS. Periodic screening for depression may be warranted.
OBJECTIVE: To compare prevalence of depression in HS patients with that of controls.
METHODS: Cross-sectional analysis of 38,140 adult and 1162 pediatric HS patients and controls identified using data from electronic health records. Primary outcome was prevalent depression.
RESULTS: Prevalence of depression among adults with HS was 30.0% (95% Confidence interval [CI], 29.6-30.5), compared with 16.9% (95% CI, 16.7-17.1) among controls. Among children and adolescents with HS, prevalence of depression was 11.7% (95% CI, 10.0-13.7), compared with 4.1% (95% CI, 3.6-4.7) among controls. In adjusted analyses, adults and children/adolescents with HS had 1.26 (95% CI, 1.25-1.28; P < .001) and 1.42 (95% CI, 0.999-2.01; P = .051) times the odds of having depression relative to controls, respectively.
LIMITATIONS: We could not evaluate the influence of disease severity on the outcome.
CONCLUSION: Depression is prevalent among children, adolescents, and adults with HS. Periodic screening for depression may be warranted.